Searched for
T BACT
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsBy this time of the year, the street usually has a fair idea of the allocations made to emerging markets by the US and other global investo...
- Domestic pharmaceutical retail market grows 11 per cent in JulyThe domestic pharmaceutical retail market saw an impressive 11% growth in July, attributed to increased sales of anti-infectives and pain r...
- GSK gets restraining order against Elder LaboratoriesGSK approached the high court against Elder Laboratories early this year for alleged infringement of trademark, including usage of identica...
- 300 drug formulations to have mandatory bar codes on packages soon to curb sales of spurious medicinesThe decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity...
- Pharma Industry staring at 30-40 bps hit on updated NLEMManchanda added that the anti-infectives treating HIV, TB and drug cessation treatments in the list doesn't have a major impact on margins ...
- GSK's pharma brands doing well: India MDThe company is also banking on its dermatology portfolio - a segment where it leads the market with brands such as Betnovate, T-Bact and Te...
- Add GlaxoSmithKline Pharma, target price Rs 1,570: Centrum BrokingThe company’s strategy of focusing on core brands and vaccines is working well for the company, says the brokerage.
- SBI, BoB and PNB can gain about 10-15%: Hemang Jani, Senior Vice President, SharekhanSomething like State Bank of India or Bank of Baroda and maybe PNB could provide about 10% to 15% of an upside purely because of this tacti...
Load More
